A combination of only 11 proteins can predict long-term disability outcomes in multiple sclerosis (MS) for different individuals. The identified proteins could be used to tailor treatments to the individual based on the expected severity of the disease.
Read more https://www.sciencedaily.com/releases/2024/01/240109121200.htm